Current methods of crystalloid preload administration prior to spinal anaesthesia for elective caesarean section are relatively ineffective in preventing hypotension. This study examined the relevance of the timing of the fluid administered. Fifty women were randomly allocated to receive either 20 ml.kg -1 of crystalloid solution during 20 minutes prior to induction of spinal anaesthesia (preload), or an equivalent volume by rapid infusion immediately after induction (coload). Significantly more patients in the coload group did not require vasopressor therapy pre-delivery (P=0.047). The coload group required a lower median dose (P=0.03) and a lower median number (P=0.04) of ephedrine doses for the treatment of maternal hypotension pre-delivery. There was no between-group difference in either the total cumulative dose, or in the total number of doses of ephedrine. Neonatal outcomes among the two groups were similar.
Hypotension following spinal anaesthesia for caesarean section is a common and troublesome complication, both from the maternal and fetal point of view. Methods for the prevention of hypotension include mechanical means such as leg wrapping 1 and anti-thromboembolic stockings, patient positioning 2 and fluid administration. Recent literature has questioned the value of traditional pre-loading techniques prior to the administration of spinal anaesthesia for caesarean section, suggesting this is relatively ineffective in the prevention of hypotension [3] [4] [5] . Preload is rapidly redistributed, and may induce atrial natri-uretic peptide secretion, resulting in peripheral vasodilatation followed by an increased rate of excretion of the preloaded fluid 6 . A more rational approach might be to apply fluid loading at the time that the local anaesthetic block is starting to take effect. This might maximize intravascular volume expansion during vasodilatation from the sympathetic blockade and limit fluid redistribution and excretion. This study was designed to test the hypothesis that rapid administration of crystalloid at the time of induction of spinal anaesthesia (coload) is associated with less hypotension than the administration of an equivalent volume of preload over 20 minutes. Of particular importance was the analysis of ephedrine requirement pre-delivery, the time period during which the risk of maternal hypotension and consequent fetal acidosis is greatest.
MATERIALS AND METHODS
The study was approved by the University of Cape Town Ethics Committee and all patients gave written informed consent. Patients weighing less than 90 kg and of ASA 1 and 2 classification, with a singleton pregnancy and presenting for elective caesarean section under spinal anaesthesia, were eligible.
Pre-eclamptic patients were excluded. Patients were kept nil by mouth from 2200 h and received cimetidine 400 mg orally on the night before and again two hours prior to surgery. On arrival in the operating theatre, 30 ml of 0.3M sodium citrate was given. A 16 gauge intravenous (IV) catheter was placed and modified Ringers lactate solution warmed to a temperature of 38°C was used.
Patients were randomly allocated to receive either preload (Group P) or coload (Group C), according to an allocation card contained within a sealed envelope. After urinary catheterization, patients were placed in the left lateral position and initial noninvasive blood pressure (BP) (Dinamap™, Critikon) and heart rate measurements performed ( Table 1 ). The patient then received either a preload of 20 ml. kg -1 of modified Ringer's lactate (Group P) (the exact fluid volume was determined by prior removal of excess fluid into a measuring cylinder) over a period of 20 minutes, or no fluid (Group C).
Immediately before starting spinal anaesthesia, three BP readings were taken in the left lateral position, with the cuff positioned at the level of the heart, at intervals of one minute. The average of the mean arterial pressure (Table 1) formed the baseline for later interventions. Spinal anaesthesia was induced in both groups using 0.5% hyperbaric bupivacaine 9 mg and fentanyl 10 µg (total volume 2.0 ml), injected slowly over 20 s at the L3/4 level with a 25 gauge Sprotte pencil-point needle (B Braun).
At the time of identification of cerebrospinal fluid, Group C patients received an identical fluid load of 20 ml. kg -1 . A pressurized giving set was opened to the patient, to administer the fluid at the maximal possible rate. Patients in both groups were then positioned supine, with 15 degrees of left lateral tilt and no additional fluid was given other than that required to keep the IV line patent.
Non-invasive BP measurements were recorded in both groups at one-minute intervals from the start of the regional block for the first 20 minutes, and then at three-minute intervals until the completion of surgery. At least two further readings were taken three minutes apart after completion of surgery, and if ephedrine was still required, readings were continued until at least 10 minutes had passed without vasopressor. If surgery was concluded in less than 30 minutes, readings were continued each three minutes until at least 30 minutes or until no further vasopressor was required. Pulse oximetry and electrocardiograph monitors were also used.
The height of the sensory block was assessed using cold sensitivity to ethyl chloride spray. Surgery was allowed to proceed after a block to T6 had been established and the block level at the end of surgery was documented ( Table 2) .
Interventions were as follows. If the mean arterial blood pressure decreased to less than 80% of the calculated baseline value, 5 mg ephedrine doses were administered every minute until mean arterial pressure recovered to within 80% of the starting value. If the blood pressure decreased to less than 70% of the calculated baseline value, ephedrine 10 mg boluses were administered until a return to within 80% of the baseline pressure occurred. Since there were clearly pre-defined target mean arterial pressures for vasopressor administration for each individual, the study was not blinded. In the event of excessive blood loss (>800 ml as assessed by suction bottle and weighing of swabs), the patient was to be withdrawn from the trial and treated appropriately.
Time periods recorded were: (1) time from completion of baseline arterial pressure determination to induction of anaesthesia (CSF time), (2) induction to skin incision, (3) induction to uterine incision, (4) uterine incision to delivery, (5) duration of administration of calculated coload volume.
At delivery all patients received 5 IU of oxytocin IV, after which no ephedrine was administered within three minutes and no further oxytocin was given intraoperatively. Maternal urine output was noted. Apgar scores were recorded at 1 and 5 minutes, and umbilical arterial pH and base deficit were measured using an automated blood gas analyser.
Estimation of sample size was based on a pilot study in which fluid volume was used to assess the efficacy of the strategies in reducing the number of ephedrine doses administered. Power analysis, based on a 25% reduction in ephedrine requirement as a clinically valid endpoint, indicated that 20 patients per group was likely to be sufficient, so we included 25 subjects per group. The null hypothesis was that there was no difference in ephedrine requirement. The primary outcome variable was the ephedrine dose requirement in the pre-delivery period.
A comparison of the number of patients in each group who did not require vasopressor employed the Fisher's Exact test. A between-group comparison of median ephedrine dose and median number of doses administered before and after delivery in each group used Kruskal-Wallis non-parametric ANOVA. For the purposes of this evaluation, each 5 mg increment of ephedrine was regarded as a unit dose. The ephedrine dose administered at each time period, in each group, was analysed using ANOVA for repeated measures. Maternal haemodynamic recordings at the various time-points were compared using analysis of variance for repeated measures. Once significant differences between groups had been defined, individually significant data points were identified using Fisher's LSD test. Maternal age, height and weight were compared using a t-test, the level of block using a Mann Whitney U test and neonatal acid-base data using unpaired Student's t-tests.
Statistical significance was assumed at a P value of <0.05.
RESULTS
Demographic data and baseline BP are presented in Table 1 . No patients were withdrawn, leaving 25 patients in each group. There were no significant differences between groups with respect to demographic parameters. Fluid preloading resulted in no significant change in mean arterial pressure in Group P (1.6 (6.2) mmHg), and during the equivalent rest period in Group C there was a non-significant decrease (2.9 (5.2) mmHg). The target arterial pressures (baseline) to guide ephedrine administration were not significantly different.
Data pertaining to fluid and anaesthesia management appear in Table 2 . There were no betweengroup differences in crystalloid volume infused, in keeping with the study design. The coload was administered over a significantly shorter period of time, according to protocol (20 versus 9.8 min, P=0.01). There were no between-group differences in any of the clinically relevant time intervals recorded. Two patients in each group experienced nausea. Neonatal data were similar (Table 3 ).
There were significant differences between groups in mean arterial pressure at 7, 8 and 9 minutes after the induction of spinal anaesthesia (Figure 1) .
Results for vasopressor management appear in Table 4 . The median cumulative dose of ephedrine required by Group C was significantly lower in the pre-delivery period (0 [0-10] versus 10 [0-20] mg, P=0.03). There were no significant differences between groups post-delivery or for total dose.
There was no significant difference between groups in the median number of unit doses of ephedrine required (P=0.054), but group C required a significantly lower number of unit doses pre-delivery (0 versus 2, P=0.04) (Figure 2 ). There were significant between-group differences in the dose used at 2, 3, 4 and 6 minutes post-induction of anaesthesia ( Figure  3 ). Significantly more patients in Group C did not require ephedrine in the pre-delivery period (P=0.047). There was a trend to more patients in Group C not requiring vasopressor during the entire procedure (P=0.057) ( Table 4 ).
Both groups showed an increase in heart rate with fluid loading. In Group P, the mean maximum increase in heart rate (22.3±19.8 beats per minute) occurred four minutes after the end of fluid administration. In Group C, the mean maximum increase 
DISCUSSION
This study found that, in the pre-delivery period when the parturient is most at risk for hypotension after spinal anaesthesia, patients receiving a rapid crystalloid infusion immediately after the induction of anaesthesia (coload) required significantly less ephedrine than those receiving a conventional preload. This was represented by a reduction in both the cumulative mean and number of unit doses of ephedrine administered. In addition, more of these patients required no ephedrine pre-delivery.
The physiological objective during spinal anaesthesia for caesarean section is the maintenance of cardiac output, and more specifically uteroplacental blood flow, although blood pressure is usually used as a surrogate index of cardiac output. A judicious combination of fluid loading and vasopressor therapy appears the most logical method of achieving this objective.
Current methods of crystalloid loading have in general been ineffective in the prevention of hypotension, and the concept of preloading has been called into question [5] [6] [7] . One study concluded that pre- 
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loading only reduced the incidence of hypotension from 71% to 55% when compared with patients receiving no preload 4 . The authors recommended that delay for the purpose of administration of a preload is not justified before urgent caesarean section. Several studies suggest that colloid solutions are more effective in the prevention of hypotension [8] [9] [10] . This is partly because colloid solutions are not as rapidly redistributed to the extracellular compartment as crystalloid solutions, thus better maintaining intravascular volume and hence cardiac output. Even if a colloid containing hydroxyethyl starch is administered as a preload, a large volume is required to sustain a rise in blood volume longer than 30 minutes 11 . Colloid solutions are expensive and not without sideeffects, so it would be clinically useful to find an alternative method of crystalloid administration associated with less hypotension. Significant increases in central venous pressure have been noted after both crystalloid and colloid preloading 12 , but there have been no reports of pulmonary oedema in any study 7 .
The relevance of the duration of crystalloid infusion prior to spinal anaesthesia for caesarean section has been investigated 3 . No difference was found in the incidence of hypotension, whether the fluid was given over 10 or 20 minutes prior to induction. However, increases in heart rate were less, and the heart rate returned to baseline in a shorter period in the 10 minute group compared with the 20 minute group, suggesting a benefit in administering the fluid closer to the time of induction of spinal anaesthesia. In our study, heart rate changes were similar to those described above, in that there was a rapid onset of a lesser increase in heart rate of shorter duration in patients who received their fluid load over a shorter time period, after induction of anaesthesia (Group C).
In the non-obstetric population, a sustained rise in cardiac output was demonstrated in a group of patients given lactated Ringer's solution after the initiation of spinal anaesthesia 13 . A kinetic analysis of an IV infusion of Ringer's solution as preload suggested that a rapid fluid administration over two minutes after induction of spinal or general anaesthesia for non-obstetric surgery might prevent hypotension caused by central hypovolaemia 14 . A study of the timing of fluid loading in general and specialty surgical patients, excluding pregnant women, reported no difference in the incidence of hypotension between groups given no fluid, a fluid preload over 20 minutes, or an identical fluid load at the time of spinal blockade. However, there was a reduction in the incidence of side-effects attributable to cardio-vascular instability following fluid loading coincident with induction of spinal anaesthesia, while administration of crystalloid prior to the performance of the block failed to prevent these side-effects 15 .
In keeping with clinical practice and the aforementioned study 15 , baseline blood pressure in our study was measured immediately before the initiation of spinal anaesthesia. Immediately following preload, there was a small increase in mean arterial pressure, while the coload group had a slight decline in pressure during this rest period. However, the target blood pressures for vasopressor treatment were not significantly different. There were no significant differences between groups in arterial pressure for the first six minutes after induction of spinal anaesthesia (during which period significantly more ephedrine was administered to the preload group) (Figure 3 ). The arterial pressure was statistically significantly, but clinically unimportantly, lower in the coload group over a three-minute period from seven to nine minutes. This confirms that less ephedrine was required pre-delivery in the coload group in order to maintain similar BP to the preload group.
This study suggests that, in comparison with the prior administration of an identical fluid load, there is a maternal advantage in administering crystalloid rapidly at the time of induction of spinal anaesthesia. In the absence of a control group receiving no intravenous fluid loading, it is possible that the results may be no better than if no preload were given. The rapid redistribution of a crystalloid preload implies that the most logical time to give such fluid is at the time of maximal risk of hypotension, that is immediately after the performance of the spinal anaesthetic. The diminution of benefit after delivery in the coload group may reflect the redistribution of crystalloid during this period. The delayed increased requirement for ephedrine in the coload group is not of clinical concern, since it occurs after delivery.
Neonatal umbilical arterial pH values were similar and base deficit values within normal limits in both groups. The good pH status of the neonates at delivery (pH values higher than in a recent metaanalysis of neonatal blood gas values 16 ) may reflect the fact that only healthy parturients with no comorbidity were studied and that the induction to delivery and uterine incision to delivery times were short. Recent literature suggests that the use of ephedrine may be associated with a lower neonatal pH and a greater neonatal base deficit than, for example, phenylephrine, during spinal anaesthesia for caesarean section 17 . It is noteworthy that there were no between-group differences in pH in this study, despite higher ephedrine requirements in the preload group.
In conclusion, an equivalent volume of crystalloid administered rapidly, immediately after the performance of spinal anaesthesia for elective caesarean section, is associated with a lower pre-delivery requirement for the vasopressor ephedrine than a conventional preload. The technique of coloading did not appear to disadvantage the neonate.
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